中文 | English
Return
Total: 93 , 1/10
Show Home Prev Next End page: GO
MeSH:(Neovascularization, Pathologic/drug therapy*)

2.Anti-angiogenesis in Lung Cancer: Current Situation, Progress and Confusion.

Zhou JIANG ; Jianhua CHEN

Chinese Journal of Lung Cancer 2022;25(4):278-286

3.Endostatin derivative angiogenesis inhibitors.

Meng-jie ZHENG

Chinese Medical Journal 2009;122(16):1947-1951

5.Mechanism exploration and future prospects of antiangiogenic agents improving tumor blood supply and oxygenation.

Xiaowen XU ; Chuangang FU

Chinese Journal of Gastrointestinal Surgery 2014;17(11):1148-1151

6.Targeting neuropilin-1 interactions is a promising anti-tumor strategy.

Shao-Dan LIU ; Li-Ping ZHONG ; Jian HE ; Yong-Xiang ZHAO

Chinese Medical Journal 2020;134(5):508-517

7.Antiangiogenesis therapy: an update after the first decade.

Sandro DE FALCO

The Korean Journal of Internal Medicine 2014;29(1):1-11

8.Research progress on anti-tumor effects by traditional Chinese medicine based on "soothing" or "blockage" regulation of tumor vessels.

Li FU ; Shu-Yang WU ; Min LI ; Yi-Han WU ; Jin-Ming ZHANG

China Journal of Chinese Materia Medica 2023;48(19):5131-5141

9.Advances in Retinopathy of Prematurity.

Xiao Xuan XU ; Ya Jun WU ; Hong Yun WU ; Yu Xiang HU ; Yi CHENG ; Li YAN ; Jie RAO ; Na WU ; Xiao Rong WU

Acta Academiae Medicinae Sinicae 2019;41(2):261-266

10.Research advance in antitumor activities of artemisinin and its derivatives.

Hua YANG ; Xian-jie TAN

Acta Academiae Medicinae Sinicae 2013;35(4):466-471

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 93 , 1/10 Show Home Prev Next End page: GO